1 - 9 out of 9Page size: 20
  1. 2024

  2. Pharmacokinetics and Dose Proportionality Study of a Novel Antiparkinsonian Agent, a 1H-1,2,4-Triazol-3-ylthio-conjugate of Prottremine

    Gorina, D. S., Lastovka, A. V., Rogachev, A. D., Podturkina, A. V., Pavlova, A. V., Ardashov, O. V., Li-Zhulanov, N. S., Tolstikova, T. G., Volcho, K. P. & Salakhutdinov, N. F., Sept 2024, In: Molecules. 29, 18, 4498.

    Research output: Contribution to journal › Article › peer-review

  3. 2022

  4. (1S,5R)-6,6-Dimethyl-4-(((1S,2S,5S)-2,6,6-trimethyl-4-oxobicyclo[3.1.1]heptan-2-yl)methyl)bicyclo[3.1.1]hept-3-en-2-one

    Ardashov, O. V., Korchagina, D. V., Bagryanskaya, I. Y., Volcho, K. P. & Salakhutdinov, N. F., 1 Dec 2022, In: MolBank. 2022, 4, M1465.

    Research output: Contribution to journal › Article › peer-review

  5. A Newly Identified Monoterpenoid-Based Small Molecule Able to Support the Survival of Primary Cultured Dopamine Neurons and Alleviate MPTP-Induced Toxicity In Vivo

    Kotliarova, A., Podturkina, A. V., Pavlova, A. V., Gorina, D. S., Lastovka, A. V., Ardashov, O. V., Rogachev, A. D., Izyurov, A. E., Arefieva, A. B., Kulikov, A. V., Tolstikova, T. G., Volcho, K. P., Salakhutdinov, N. F. & Sidorova, Y., Dec 2022, In: Molecules. 27, 23, 8286.

    Research output: Contribution to journal › Article › peer-review

  6. MPTP-Treated Zebrafish Recapitulate ‘Late-Stage’ Parkinson’s-like Cognitive Decline

    Bashirzade, A. A. O., Cheresiz, S. V., Belova, A. S., Drobkov, A. V., Korotaeva, A. D., Azizi-Arani, S., Azimirad, A., Odle, E., Gild, E. Y. V., Ardashov, O. V., Volcho, K. P., Bozhko, D. V., Myrov, V. O., Kolchanova, S. M., Polovian, A. I., Galumov, G. K., Salakhutdinov, N. F., Amstislavskaya, T. G. & Kalueff, A. V., Feb 2022, In: Toxics. 10, 2, 69.

    Research output: Contribution to journal › Article › peer-review

  7. 2019

  8. A Novel Small Molecule Supports the Survival of Cultured Dopamine Neurons and May Restore the Dopaminergic Innervation of the Brain in the MPTP Mouse Model of Parkinson's Disease

    Ardashov, O. V., Pavlova, A. V., Mahato, A. K., Sidorova, Y., Morozova, E. A., Korchagina, D. V., Salnikov, G. E., Genaev, A. M., Patrusheva, O. S., Li-Zhulanov, N. S., Tolstikova, T. G., Volcho, K. P. & Salakhutdinov, N. F., 16 Oct 2019, In: ACS chemical neuroscience. 10, 10, p. 4337-4349 25 p.

    Research output: Contribution to journal › Article › peer-review

  9. 2018

  10. Preparation of chiral isobenzofurans from 3-carene in the presence of modified clays

    Sidorenko, A. Y., Il'ina, I. V., Kravtsova, A. V., Aho, A., Ardashov, O. V., Li-Zhulanov, N. S., Volcho, K. P., Salakhutdinov, N. F., Murzin, D. Y. & Agabekov, V. E., 1 Nov 2018, In: Molecular Catalysis. 459, p. 38-45 8 p.

    Research output: Contribution to journal › Article › peer-review

  11. Preparation of octahydro-2H-chromen-4-ol with analgesic activity from isopulegol and thiophene-2-carbaldehyde in the presence of acid-modified clays

    Sidorenko, A. Y., Kravtsova, A. V., Wärnå, J., Aho, A., Heinmaa, I., Il'ina, I. V., Ardashov, O. V., Volcho, K. P., Salakhutdinov, N. F., Murzin, D. Y. & Agabekov, V. E., 1 Jul 2018, In: Molecular Catalysis. 453, p. 139-148 10 p.

    Research output: Contribution to journal › Article › peer-review

  12. 2017

  13. Evolution of anti-parkinsonian activity of monoterpenoid (1R,2R,6S)-3-methyl-6-(prop-1-en-2-yl)cyclohex-3-ene-1,2-diol in various in vivo models

    Valdman, E., Kapitsa, I., Ivanova, Е., Voronina, T., Ardashov, O., Volcho, K., Khazanov, V. & Salakhutdinov, N., 15 Nov 2017, In: European Journal of Pharmacology. 815, p. 351-363 13 p.

    Research output: Contribution to journal › Article › peer-review

  14. Synthesis and analgesic activity of monoterpenoid-derived alkyl-substituted chiral hexahydro-2H-chromenes

    Il’ina, I., Pavlova, A., Korchagina, D., Ardashov, O., Tolstikova, T., Volcho, K. & Salakhutdinov, N., 1 Jul 2017, In: Medicinal Chemistry Research. 26, 7, p. 1415-1426 12 p.

    Research output: Contribution to journal › Article › peer-review

ID: 3433702